Total Payments
$6,942
2024 Payments
$541.79
Companies
44
Transactions
480
Medicare Patients
14,944
Medicare Billing
$737,861
Payment Breakdown by Category
Food & Beverage$6,914 (99.6%)
Education$28.15 (0.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,914 | 475 | 99.6% |
| Education | $28.15 | 5 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,061 | 87 | $0 (2024) |
| Amgen Inc. | $792.54 | 54 | $0 (2023) |
| Lilly USA, LLC | $588.17 | 48 | $0 (2024) |
| ABBVIE INC. | $464.26 | 37 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $456.47 | 31 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $448.16 | 19 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $368.85 | 31 | $0 (2023) |
| Merck Sharp & Dohme LLC | $350.20 | 26 | $0 (2022) |
| GlaxoSmithKline, LLC. | $319.51 | 19 | $0 (2024) |
| PFIZER INC. | $318.94 | 22 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $541.79 | 29 | Novo Nordisk Inc ($113.34) |
| 2023 | $667.19 | 48 | ABBVIE INC. ($236.94) |
| 2022 | $81.75 | 5 | Novo Nordisk Inc ($34.28) |
| 2021 | $399.23 | 25 | Novo Nordisk Inc ($99.91) |
| 2020 | $304.01 | 23 | Novo Nordisk Inc ($116.68) |
| 2019 | $1,240 | 96 | Amgen Inc. ($205.52) |
| 2018 | $1,952 | 127 | Amgen Inc. ($296.44) |
| 2017 | $1,757 | 127 | AstraZeneca Pharmaceuticals LP ($188.63) |
All Payment Transactions
480 individual payment records from CMS Open Payments — Page 1 of 20
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/30/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $23.23 | General |
| Category: NEUROSCIENCE | ||||||
| 07/26/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $29.83 | General |
| Category: NEUROSCIENCE | ||||||
| 07/24/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.86 | General |
| Category: Diabetes | ||||||
| 07/24/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $15.22 | General |
| Category: RESPIRATORY | ||||||
| 07/23/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $16.80 | General |
| Category: PAIN | ||||||
| 07/19/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $22.79 | General |
| Category: NEUROSCIENCE | ||||||
| 07/16/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $23.68 | General |
| Category: Biological | ||||||
| 07/01/2024 | Amneal Pharmaceuticals LLC | UNITHROID (Drug) | Food and Beverage | In-kind items and services | $13.15 | General |
| Category: ENDOCRINOLOGY | ||||||
| 06/27/2024 | PFIZER INC. | PREVNAR 20 (Biological) | Food and Beverage | In-kind items and services | $18.70 | General |
| Category: VACCINES | ||||||
| 06/18/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $16.67 | General |
| Category: PAIN | ||||||
| 06/17/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $15.96 | General |
| Category: Diabetes | ||||||
| 06/10/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | TRADJENTA (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $27.92 | General |
| Category: DIABETES | ||||||
| 06/03/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.01 | General |
| Category: Diabetes | ||||||
| 05/28/2024 | Tris Pharma Inc | Dyanavel XR (Drug) | Food and Beverage | In-kind items and services | $17.35 | General |
| Category: ADHD | ||||||
| 05/16/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.76 | General |
| Category: Diabetes | ||||||
| 05/14/2024 | PFIZER INC. | PREVNAR 20 (Biological) | Food and Beverage | In-kind items and services | $16.45 | General |
| Category: VACCINES | ||||||
| 05/01/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $14.26 | General |
| Category: RESPIRATORY | ||||||
| 04/23/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.75 | General |
| Category: Diabetes | ||||||
| 03/20/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $20.47 | General |
| Category: Respiratory | ||||||
| 03/19/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $20.47 | General |
| Category: Respiratory | ||||||
| 03/15/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $19.84 | General |
| Category: PSYCHIATRY | ||||||
| 03/14/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.21 | General |
| Category: Diabetes | ||||||
| 03/07/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $13.29 | General |
| Category: Oncology | ||||||
| 02/26/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $16.36 | General |
| Category: Diabetes | ||||||
| 02/19/2024 | Tolmar, Inc. | JATENZO (Drug) | Food and Beverage | Cash or cash equivalent | $13.40 | General |
| Category: HORMONE REPLACEMENT | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 37 | 4,167 | 5,295 | $404,434 | $220,820 |
| 2022 | 40 | 3,805 | 4,814 | $355,331 | $196,641 |
| 2021 | 40 | 3,805 | 4,864 | $340,169 | $182,578 |
| 2020 | 36 | 3,167 | 4,227 | $282,913 | $137,822 |
Total Patients
14,944
Total Services
19,200
Medicare Billing
$737,861
Procedure Codes
153
All Medicare Procedures & Services
153 procedure records from CMS Medicare Utilization — Page 1 of 7
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 658 | 1,036 | $170,940 | $87,780 | 51.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 269 | 269 | $36,315 | $34,698 | 95.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 356 | 440 | $50,600 | $25,094 | 49.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 87 | 97 | $17,945 | $13,037 | 72.7% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 104 | 104 | $9,360 | $7,477 | 79.9% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 19 | 19 | $5,650 | $5,015 | 88.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 364 | 532 | $5,320 | $4,469 | 84.0% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 26 | 26 | $6,240 | $4,183 | 67.0% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2023 | 110 | 115 | $8,625 | $3,981 | 46.2% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 105 | 214 | $9,630 | $3,471 | 36.0% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 192 | 203 | $10,150 | $3,341 | 32.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 107 | 107 | $3,745 | $3,226 | 86.1% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 255 | 311 | $11,196 | $3,209 | 28.7% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 167 | 167 | $4,509 | $3,086 | 68.4% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 194 | 205 | $8,610 | $2,690 | 31.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 17 | 17 | $3,468 | $2,180 | 62.8% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 236 | 265 | $6,360 | $2,003 | 31.5% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 120 | 161 | $3,220 | $1,507 | 46.8% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2023 | 11 | 11 | $1,650 | $1,439 | 87.2% |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | Office | 2023 | 73 | 73 | $4,015 | $1,381 | 34.4% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 35 | 35 | $1,050 | $1,029 | 98.0% |
| 82306 | Vitamin d-3 level | Office | 2023 | 34 | 35 | $3,325 | $1,015 | 30.5% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 74 | 92 | $2,852 | $918.86 | 32.2% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 67 | 67 | $4,355 | $694.37 | 15.9% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 11 | 39 | $1,365 | $683.97 | 50.1% |
About Dr. David Evans, MD
Dr. David Evans, MD is a Family Medicine healthcare provider based in Warrenton, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/08/2006. The National Provider Identifier (NPI) number assigned to this provider is 1346299443.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Evans, MD has received a total of $6,942 in payments from pharmaceutical and medical device companies, with $541.79 received in 2024. These payments were reported across 480 transactions from 44 companies. The most common payment nature is "Food and Beverage" ($6,914).
As a Medicare-enrolled provider, Evans has provided services to 14,944 Medicare beneficiaries, totaling 19,200 services with total Medicare billing of $737,861. Data is available for 4 years (2020–2023), covering 153 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Warrenton, VA
- Active Since 05/08/2006
- Last Updated 11/05/2024
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1346299443
Products in Payments
- Ozempic (Drug) $635.02
- Prolia (Biological) $316.71
- JARDIANCE (Drug) $277.35
- XARELTO (Drug) $236.81
- TRULICITY (Drug) $229.34
- Aimovig (Biological) $212.27
- JANUVIA (Drug) $209.43
- Livalo (Drug) $198.76
- TRELEGY ELLIPTA (Drug) $195.20
- BEVESPI AEROSPHERE (Drug) $166.51
- TRADJENTA (Drug) $162.85
- Trintellix (Drug) $150.85
- TOUJEO (Drug) $147.85
- XIFAXAN (Drug) $146.09
- VRAYLAR (Drug) $135.65
- INVOKANA (Drug) $132.04
- FARXIGA (Drug) $122.29
- QULIPTA (Drug) $114.44
- Xultophy 100/3.6 (Drug) $114.04
- Repatha (Biological) $99.40
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Warrenton
Dr. James Grimes, M.d, M.D
Family Medicine — Payments: $9,747
Family Medicine $9,747
Dr. Michael Lin, M.d, M.D
Family Medicine — Payments: $8,881
Family Medicine $8,881
Dr. Charles Coyne, M.d, M.D
Family Medicine — Payments: $5,656
Family Medicine $5,656
Ahmad Babar, M.d, M.D
Family Medicine — Payments: $3,580
Family Medicine $3,580
Steven Von Elten, Md, MD
Family Medicine — Payments: $3,409
Family Medicine $3,409
Gregory Golub, Md, MD
Family Medicine — Payments: $2,548
Family Medicine $2,548